Comparison of Outcomes following Transhiatal or Ivor Lewis Esophagectomy for Esophageal Carcinoma

1999 ◽  
Vol 23 (3) ◽  
pp. 271-276 ◽  
Author(s):  
Laurence Gluch ◽  
Ross C. Smith ◽  
Christopher P. Bambach ◽  
Alastair R. Brown
Keyword(s):  
Esophageal Carcinoma ◽  
Ivor Lewis ◽  
Ivor Lewis Esophagectomy

scholarly journals Comparative analysis of long-term oncologic outcomes for minimally invasive and open Ivor Lewis esophagectomy after neoadjuvant chemoradiation: a propensity score matched observational study

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Robert E. Merritt ◽  
Peter J. Kneuertz ◽  
Mahmoud Abdel-Rasoul ◽  
Desmond M. D’Souza ◽  
Kyle A. Perry
Keyword(s):  
Esophageal Carcinoma ◽  
Complete Response ◽  
Neoadjuvant Chemoradiation ◽  
Oncologic Outcomes ◽  
Recurrence Free Survival ◽  
Trimodality Therapy ◽  
Ivor Lewis ◽  
Free Survival ◽  
Ivor Lewis Esophagectomy

Abstract Background Locally advanced esophageal carcinoma is typically treated with neoadjuvant chemoradiation and esophagectomy (trimodality therapy). We compared the long-term oncologic outcomes of minimally invasive Ivor Lewis esophagectomy (M-ILE) cohort with a propensity score weighted cohort of open Ivor Lewis esophagectomy (O-ILE) cases after trimodality therapy. Methods This is a retrospective review of 223 patients diagnosed with esophageal carcinoma who underwent neoadjuvant chemoradiation followed by M-ILE or O-ILE from April 2009 to February 2019. Inverse probability of treatment weighting (IPTW) adjustment was used to balance the baseline characteristics between study groups. Kaplan–Meier survival curves were calculated for overall survival and recurrence-free survival comparing the two groups. Multivariate Cox proportional hazards regression models were used to determine predictive variables for overall and recurrence-free survival. Results The IPTW cohort included patients with esophageal carcinoma who underwent M-ILE (n = 142) or O-ILE (n = 68). The overall rate of postoperative adverse events was not significantly different after IPTW adjustment between the O-ILE and M-ILE trimodality groups (53.4% vs. 39.2%, p = 0.089). The 3-year overall survival (OS) for the M-ILE group was 59.4% (95% CI: 49.8–67.8) compared to 55.7% (95% CI: 39.2–69.4) for the O-ILE group (p = 0.670). The 3-year recurrence-free survival for the M-ILE group was 59.9% (95% CI: 50.2–68.2) compared to 61.6% (95% CI: 41.9–76.3) for the O-ILE group (p = 0.357). A complete response to neoadjuvant chemoradiation was significantly predictive of improved OS and RFS. Conclusion The overall and recurrence-free survival rates for M-ILE were not significantly different from O-ILE for esophageal carcinoma after trimodality therapy. Complete response to neoadjuvant chemoradiation was predictive of improved overall and recurrence- free survival.

scholarly journals Ivor-Lewis esophagectomy versus one-incision esophagectomy via the left thoracic approach in the treatment of middle and lower thoracic esophageal carcinoma

2013 ◽  
Vol 21 (33) ◽  
pp. 3710
Author(s):  
Guo-Qing Lu ◽  
Gang Li ◽  
Ainiwaer·Julaiti ◽  
De-Sheng Li ◽  
Xiaheding·Yiliyaer ◽  
...  
Keyword(s):  
Esophageal Carcinoma ◽  
Ivor Lewis ◽  
Ivor Lewis Esophagectomy ◽  
Thoracic Approach

Indocyanine green perfusion assessment of the gastric conduit in minimally invasive Ivor Lewis esophagectomy

2021 ◽  
Author(s):  
Keouna Pather ◽  
Adeline M. Deladisma ◽  
Christina Guerrier ◽  
Isaac R. Kriley ◽  
Ziad T. Awad
Keyword(s):  
Minimally Invasive ◽  
Indocyanine Green ◽  
Gastric Conduit ◽  
Ivor Lewis ◽  
Ivor Lewis Esophagectomy ◽  
Perfusion Assessment

Major modifications to minimize thoracic esophago‐gastric leak and eradicate esophageal stricture after Ivor Lewis esophagectomy

2021 ◽  
Author(s):  
Brian Housman ◽  
Dong‐Seok Lee ◽  
Andrea Wolf ◽  
Daniel Nicastri ◽  
Andrew Kaufman ◽  
...  
Keyword(s):  
Esophageal Stricture ◽  
Gastric Leak ◽  
Ivor Lewis ◽  
Ivor Lewis Esophagectomy

PS02.147: MANAGEMENT OF A SIMULTANEOUS HIGH ESOPHAGO-TRACHEAL FISTULA CAUSED BY ESOPHAGEAL STENT DUE TO ANASTOMOTIC LEAKAGE AFTER IVOR-LEWIS ESOPHAGECTOMY: A CASE REPORT

2018 ◽  
Vol 31 (Supplement_1) ◽  
pp. 162-162
Author(s):  
Hannah Andrae ◽  
Thomas Musholt ◽  
Hauke Lang ◽  
Peter Grimminger
Keyword(s):  
Case Report ◽  
Anastomotic Leakage ◽  
Healing Process ◽  
Esophageal Stent ◽  
Neoadjuvant Radiochemotherapy ◽  
Carcinoma Of The Esophagus ◽  
Ivor Lewis ◽  
Ivor Lewis Esophagectomy ◽  
First Choice ◽  
Cervical Surgery

Abstract Background Esophagotracheal perforation is a very severe complication. However, an esophagotracheal perforation caused due to an esophageal stent after anastomotic leakage after ivor-lewis resection, is even more complex and associated with high mortality. Therefore we present a case how we managed a high esophagotracheal perforation and anastomotic leakage after ivor-lewis resection of esophageal cancer, prior treated with neoadjuvant radiochemotherapy. Methods Case report A 71-year old patient was transferred to our center due to an esophagotracheal perforation at the proximal stent—and at 18–20 cm from the front teeth row. The stent had been placed due to anastomotic leakage after ivor-lewis resection. The patient's history began with a squamous cell carcinoma of the esophagus, treated with neoadjuvant radiochemotherapy and followed by ivor-lewis esophagectomy. She developed an anastomotic leakage, which was treated with an esophageal stent. This stent perforated and caused a fistula between the esophagus and the trachea. Results After transfer to our center, we performed a tracheotomia with a tubus blocked, distal of the esophagotracheal fistula, to prevent a respiratory insufficiency. We removed the dislocated stent and induced an endosponge therapy. A prolonged healing process lead to a step-by-step decrease of the anastomotic leakage. Finally, the semicircular hole could be supplied by a fibrin sealant. We resected the fistula via cervical surgery and placed a pectoralis muscle flap between trachea and esophagus. The surgery was performed under steady neuromonitoring control. The postoperative course was uncomplicated. The patient could be extubated with spontaneous breathing. Eleven days after surgery, the patient could be discharged fully enteralised. The stomach interponate could be kept. Half a year later, our patient shows up in our regular consultation, reporting no dysphagia. Conclusion Our experience with endosponge treatment suggests that this is the first choice for successful healing of anastomotic leakage after ivor-lewis resection. A stenting of the esophagus after finding an anastomotic leakage can be considered, but is associated with a risk of further complication. Disclosure All authors have declared no conflicts of interest.

Long-term outcomes after robotic-assisted Ivor Lewis esophagectomy

2021 ◽  
Author(s):  
Pridvi Kandagatla ◽  
Ali Hussein Ghandour ◽  
Ali Amro ◽  
Andrew Popoff ◽  
Zane Hammoud
Keyword(s):  
Long Term Outcomes ◽  
Ivor Lewis ◽  
Robotic Assisted ◽  
Ivor Lewis Esophagectomy
Sign in / Sign up

Export Citation Format

Share Document